Know Cancer

or
forgot password

    • cancer clinical trials in palm springs, CA

    • Vaccine Therapy for Patients With Stage IV Melanoma
    Comprehensive Cancer Center at DRMC
    Palm Springs, California 92262
    Malignant Melanoma
    Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Breast Cancer
    Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Breast Cancer
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Lymphoma
    Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Multiple Myeloma and Plasma Cell Neoplasm
    Vaccine Therapy for Patients With Stage III Melanoma
    Comprehensive Cancer Center at DRMC
    Palm Springs, California 92262
    Malignant Melanoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Vaccine Therapy in Treating Patients With Malignant Melanoma
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Melanoma (Skin)
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Desert Regional Medical Center
    Palm Springs, California 92262
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Multiple Myeloma and Plasma Cell Neoplasm
    Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Non-small Cell Lung Cancer
    Phase II Study in Patients With Operable Breast Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Colorectal Cancer
    Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Pancreatic Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Desert Regional Medical Center
    Palm Springs, California 92262
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Lung Cancer
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Comprehensive Cancer Center CCC - Palm Spriings
    Palm Springs, California 92262
    Myelodysplastic Syndromes
    IMGN901 in Combination With Lenalidomide and Dexamethasone
    Comprehensive Cancer Center of the Desert
    Palm Springs, California 92262
    Multiple Myeloma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Colorectal Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Desert Regional Medical Center
    Palm Springs, California 92262
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1
    Desert Oasis Healthcare Medical Group

    Trial Locations
    Desert Oasis Healthcare Medical Group
    Desert Medical Group, Inc., dba Desert Oasis Healthcare Medical Group
    HIV-1
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Comprehensive Cancer Center - Palm Springs
    Palm Springs, California
    Breast Cancer
    A Safety Study of Carfilzomib With Cyclophosphamide and Dexamethasone Prior to Autologous Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Multiple Myeloma
    A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
    Desert Univ School of Medicine
    Palm Springs, California 92262
    Sarcoma, Kaposi, HIV Infections
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Breast Cancer
    Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Anemia, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Breast Cancer
    Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Colorectal Cancer
    S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Breast Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Lung Cancer
    D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Fatigue, Neoplasms
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Myelodysplastic Syndromes
    Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
    Comprehensive Cancer Centers of the Desert
    Palm Springs, California 92262
    Colorectal Neoplasms
    Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
    Comprehensive Cancer Center at DRMC

    Trial Locations
    Comprehensive Cancer Center at DRMC
    Desert Regional Medical Center
    Esophageal Neoplasms, Stomach Neoplasms, Adenocarcinoma
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Comprehensive Cancer Center at Desert Regional Medical Center
    Palm Springs, California 92262
    Lung Cancer
    S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Esophageal Cancer
    Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Sarcoma
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Esophageal Cancer
    Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab
    Comprehensive Cancer Center - Desert Regional Medical Center
    Palm Springs, California 92662
    Non-Hodgkin's Lymphoma
    A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
    The Center for Advanced Research and Education, Inc.
    Palm Springs, California 92262
    Uterine Cervical Dysplasia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Desert Regional Medical Center
    Palm Springs, California 92262
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
    MDDesert Comprehensive Breast Center
    Palm Springs, California 92262
    Breast Cancer
    S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
    Desert Regional Medical Center Comprehensive Cancer Center
    Palm Springs, California 92262
    Gastric Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Desert Med Grp Inc, Dba Desert Oasis Healthcare Med Group
    Palm Springs, California 92262
    Atrial Fibrillation, Atrial Flutter
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Comprehensive Cancer Care
    Palm Springs, California 92262
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
    Comprehensive Cancer Center at Desert Mountain
    Palm Springs, California 92262
    Prostate Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 094
    Palm Springs, California 92262
    Hypoactive Sexual Desire Disorder